Aqneursa
Payments companies reported to CMS as associated with Aqneursa. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Aqneursa, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Aqneursa
These are the largest totals companies reported as associated with Aqneursa. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Walla Al-Hertani | Orange, CA | Clinical Genetics (M.D.) | $1,671.88 |
| Thomas Burrow | Little Rock, AR | Clinical Genetics (M.D.) | $1,575.00 |
| Staci Kallish | Philadelphia, PA | Clinical Genetics (M.D.) | $1,560.00 |
| Joshua Baker | Chicago, IL | Clinical Genetics (M.D.) | $1,560.00 |
| Aaina Kochhar | Aurora, CO | Clinical Genetics (M.D.) | $1,485.00 |
| Caroline Hastings | Oakland, CA | Pediatric Hematology-Oncology | $508.48 |
| Rachel Leibowitz | Washington, DC | Pediatrics (Nurse Practitioner) | $221.41 |
| Sergio Jacinto | Tampa, FL | Neurology With Special Qualifications In Child Neurology | $188.38 |
| Kristin Fritch | Tampa, FL | Nurse Practitioner | $159.84 |
| Can Ficicioglu | Philadelphia, PA | Clinical Genetics (M.D.) | $157.71 |
Prescribed Aqneursa?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.